Terms: = Sarcomas AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
6 results:
1. Clinical utility of susceptibility-weighted MR sequence for the evaluation of uterine sarcomas.
Takeuchi M; Matsuzaki K; Harada M
Clin Imaging; 2019; 53():143-150. PubMed ID: 30340078
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of Red Degeneration of Uterine Leiomyoma with Susceptibility-weighted MR Imaging.
Takeuchi M; Matsuzaki K; Bando Y; Harada M
Magn Reson Med Sci; 2019 Apr; 18(2):158-162. PubMed ID: 30270253
[TBL] [Abstract] [Full Text] [Related]
3. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract] [Full Text] [Related]
4. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas.
Wysoczynski M; Miekus K; Jankowski K; Wanzeck J; Bertolone S; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Cancer Res; 2007 Mar; 67(5):2131-40. PubMed ID: 17332343
[TBL] [Abstract] [Full Text] [Related]
5. Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred, including a case of Sturge-Weber syndrome.
Lynch HT; McComb RD; Osborn NK; Wolpert PA; Lynch JF; Wszolek ZK; Sidransky D; Steg RE
Cancer; 2000 Jan; 88(2):433-9. PubMed ID: 10640978
[TBL] [Abstract] [Full Text] [Related]
6. Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usage.
Wang Z; Melmed S
J Biol Chem; 1997 Oct; 272(44):27957-65. PubMed ID: 9346946
[TBL] [Abstract] [Full Text] [Related]
